Clinical trial Recruiting at 2 sites Observational Ages 18 to 99

Registry for patients with obstructive sleep apnea treated with hypoglossal nerve stimulation

Official title: Hypoglossal Nerve Stimulation (HNS) Therapy in Patients With Obstructive Sleep Apnea (OSA): Belgian Registry

Run by University Hospital, Antwerp · NCT06332404 · Data updated 2026-11-12

This study is collecting information from patients with moderate to severe obstructive sleep apnea who are using a new device called Inspire to see how well it works and how it helps them over five years.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment225 (estimated)
SponsorUniversity Hospital, Antwerp
Academic / other
Locations2 sites (Edegem, Antwerp and 1 other locations)
StatusRecruiting
StartedApril 18, 2024
Main results expectedApril 2034
Study endsApril 2034
Registry record updatedSeptember 15, 2025
Trial IDNCT06332404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are adults aged 18 and older with moderate to severe obstructive sleep apnea who have not responded to or cannot tolerate traditional treatments like CPAP.

Probably not a fit

Patients with a body mass index over 32 kg/m² or those with specific anatomical issues that could hinder the effectiveness of the HNS therapy may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect data on patients with moderate to severe obstructive sleep apnea (OSA) who are treated with hypoglossal nerve stimulation (HNS) using the Inspire system in Belgium. Patients implanted with the Inspire device will be invited to participate, and data will be gathered during routine clinical visits over a five-year period. The collected data will include polysomnographic results, therapy usage, device performance, and patient-reported outcomes through various questionnaires. This observational approach allows for the assessment of the effectiveness and safety of HNS therapy in a real-world clinical setting.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of hypoglossal nerve stimulation therapy for patients with obstructive sleep apnea.

How similar studies have gone: While this registry approach is not novel, similar studies have shown success in evaluating the effectiveness of hypoglossal nerve stimulation in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Any patient implanted with or receiving the Inspire HNS system and who is able to give informed consent is eligible to participate in the registry. A patient is eligible for HNS implantation if he/she meets the following criteria:

* At least 18 years old at the time of implantation
* The patient suffers from moderate to severe OSA (15 events/h ≤ AHI ≤ 65 events/h)
* The patient has failed, not tolerated or has a contraindication for continuous positive airway pressure (CPAP) and/or mandibular advancement device (MAD) therapy
* Absence of complete concentric collapse of the level of the soft palate during Drug-Induced Sleep Endoscopy (DISE)

Exclusion Criteria:

* Body mass index (BMI) \>32 kg/m².
* Combined mixed and central AHI is more than 25% of the total AHI
* Patients with complete concentric collapse at the level of the soft palate or any other anatomical deviation that could impede the proper functioning of HNS
* Patients with severely impaired neurological control over the upper airway
* Pregnancy
* Surgery performed on the soft palate in the past three months before implantation.

Where it's running

  • Antwerp University Hospital
    Edegem, Antwerp, Belgium
    Recruiting
  • AZ Sint-Jan Brugge
    Bruges, West-Vlaanderen, Belgium
    Recruiting

Study contacts

  • Principal investigator: Olivier Vanderveken, MD, PhD — University Hospital, Antwerp
  • Study coordinator: Dorine Van Loo, MSc
  • Email: dorine.vanloo@uza.be
  • Phone: +3238215780

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.